Wells Fargo & Company Axsome Therapeutics, Inc. Call Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$376 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$313 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$267 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$197 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$109 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.59B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...